Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Cipla targets South African asthma market with breath activated inhaler

19-Jan-2017 - Cipla has launched a breath activated inhaler in South Africa.

MannKind ‘aggressively’ moving forward with inhalable epinephrine

16-Jan-2017 - MannKind Corporation met with the US FDA last month to discuss a single-use disposable epinephrine inhaler it says could be an affordable alternative to the Epipen.

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

Proveca hires Quotient unit to develop more kid-friendly formulations

10-Jan-2017 - Quotient Clinical has been hired to develop child-friendly formulations of several off-patent drugs by Proveca Ltd.

Aurobindo to add Portuguese capsule and tablet capacity through Generis Farmaceutica buy

09-Jan-2017 - Aurobindo Pharma Limited has agreed to buy Portugal-based Generis Farmaceutica SA for €135m in a deal that includes a tablet and capsule plant in Amadora.

Shire offloads mRNA tech and staff to RaNa Therapeutics

05-Jan-2017 - Shire has sold its MRT messenger RNA platform to RaNA Therapeutics but will retain an equity stake in the Cambridge, Massachusetts-based biotech.

Intarcia receives $140m Gates Foundation grant for needle-free HIV tech

04-Jan-2017 - The Gates Foundation has invested $140m in Intarcia Therapeutics Inc to develop the biotech’s needle-free delivery pump for use with an HIV prophylactic therapy.

Prokarium and Probiomed team to scale-up thermostable oral vaccine

04-Jan-2017 - The project funded by the UK and Mexican governments will look to prove the scalability of Prokarium’s oral vaccine platform, the firm says.

AstraZeneca opens UK Zoladex plant

21-Dec-2016 - AstraZeneca has opened a £120m ($148m) cancer treatment manufacturing site in Macclesfield in the UK.

News in brief

Claris to sell injectable drug business and facilities to Baxter

19-Dec-2016 - Baxter International has agreed to pay Claris Lifesciences $625m (€598m) for three manufacturing facilities and a portfolio of 11 approved injectable drugs.

Lonza to buy Capsugel for $5.5bn, no site divestitures planned

15-Dec-2016 - Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings of CHF100m a year by 2019.

US FDA slams delivery patch firm Pocono Coated Products over sub-potent meds

14-Dec-2016 - The US FDA has criticized Pocono Coated Products' (PCP) efforts to bring its transdermal patch plant in Cherryville, North Carolina into compliance with cGMP standards.

Lonza confirms interest in Capsugel takeover

12-Dec-2016 - Lonza has confirmed it is interested in buying Capsugel. 

Growth in biologics and vaccines leading injectables business, Aptar Pharma

12-Dec-2016 - Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.

Needle-free Zika vaccine shows promise in clinical trial

07-Dec-2016 - As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and training to the NIH.


Takeda overturns negative EU CHMP opinion for oral drug Ninlaro in ‘face-to-face’ appeal

06-Dec-2016 - Takeda was awarded conditional EU marketing authorisation of the small molecule drug Ninlaro, overturning the EMA’s negative opinion on its efficacy against Multiple Myeloma (MM).

AstraZeneca sets out on a $1bn 'Bicycle' path

06-Dec-2016 - AstraZeneca has partnered with Bicycle Therapeutics in a potential $1bn deal to develop a new class of small molecules which have antibody-like properties.

News in brief

Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment

02-Dec-2016 - Arrowhead Pharmaceuticals Inc. has also laid off its Chief scientific officer David Lewis - as part of the 34 staff cull - after several trials using delivery vehicle Ex1 were stopped by the firm.

Arrowhead halts development of RNAi-based therapies that use its Ex1 delivery tech

30-Nov-2016 - Arrowhead has abandoned development of therapies which use its Ex1 delivery vehicle, axing multiple clinical trials and sacking staff.

West completes Mulhuddart expansion citing insulin as driver

30-Nov-2016 - Delivery device with West Pharmaceutical Services has completed the expansion of its plant in Mulhuddart, County Dublin.

Catalent adding OTC capsule maker Accucaps to global softgel network

28-Nov-2016 - Catalent will add two Canadian manufacturing facilities to its softgel network through the acquisition of Accucaps.

Evonik to construct second Alabama facility for drug delivery polymers

23-Nov-2016 - Evonik has laid plans to expand a polymer facility in Alabama to cater for growing demand for sophisticated drug delivery and medical devices.


US FDA lifts clinical hold after Aduro modifies listeria-based therapy trials

22-Nov-2016 - The US FDA has cleared Aduro Biotech to recruit for trials of its listeria-based immunotherapies after the firm modified protocols to reduce the risk of subjects developing listeriosis.

Swallowing Stars: MIT spin-out invents gastric device which solves problem of daily dosing

22-Nov-2016 - Lyndra Inc. has developed a star shaped gastric device which claims to solve the problem of delivering drugs with short half-lives.

MIT’s Langer sells off excipients biotech to break into Biosimilar market

21-Nov-2016 - Eagle Pharmaceuticals Inc. has announced its intention to buy Arsia Therapeutics citing its formulation viscosity reduction platform as the driver for the deal.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...